Masato Terashima

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

Eri Banno, Yosuke Togashi, Yu Nakamura et al. · Cancer Science · 2016 · 87 citations · Full text

Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer

Yosuke Togashi, Akihiro Kogita, Hiroki Sakamoto et al. · Cancer Letters · 2014 · 85 citations

Tumor Biology, Pancreatic Cancer, Medicine +7

Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer

Masayuki Takeda, Kazuko Sakai, Masato Terashima et al. · Annals of Oncology · 2015 · 81 citations · Full text

Oncology, Engineering, Medicine +10

Frequent amplification of <i>ORAOV1</i> gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production

Yosuke Togashi, Tokuzo Arao, Hiroaki Kato et al. · Oncotarget · 2013 · 61 citations · Full text

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

Akihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi et al. · International Journal of Oncology · 2014 · 55 citations · Full text

Hypoxia Induces Resistance, Alk Inhibitors, Oncology +14